CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 393 of 1
Non-Antibody Products
Page 393 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 100 g | 36375-100 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 250 g | 36375-250 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 50 g | 36375-50 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 500 g | 36375-500 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 1 mg | 34731-1 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 10 mg | 34731-10 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 25 mg | 34731-25 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 5 mg | 34731-5 | More Info |
| DL-Sulforaphane N-acetyl-L-cysteine | A major metabolite of sulforaphane that has been shown induce ARE-driven g… | 1 mg | 16098-1 | More Info |
| DL-Sulforaphane N-acetyl-L-cysteine | A major metabolite of sulforaphane that has been shown induce ARE-driven g… | 10 mg | 16098-10 | More Info |
| DL-Sulforaphane N-acetyl-L-cysteine | A major metabolite of sulforaphane that has been shown induce ARE-driven g… | 5 mg | 16098-5 | More Info |
| DL-TBOA | An EAAT inhibitor (IC50s = 67 and 5.5 µM for glutamate uptake in COS… | 10 mg | 29632-10 | More Info |
| DL-TBOA | An EAAT inhibitor (IC50s = 67 and 5.5 µM for glutamate uptake in COS… | 5 mg | 29632-5 | More Info |
| DL-threo-β-Hydroxyaspartic Acid | An EAAT inhibitor; inhibits glutamate uptake in COS-1 cells expressing hum… | 100 mg | 35274-100 | More Info |
| DL-threo-β-Hydroxyaspartic Acid | An EAAT inhibitor; inhibits glutamate uptake in COS-1 cells expressing hum… | 25 mg | 35274-25 | More Info |
| DL-threo-β-Hydroxyaspartic Acid | An EAAT inhibitor; inhibits glutamate uptake in COS-1 cells expressing hum… | 50 mg | 35274-50 | More Info |
| DL-threo-Isocitric Acid (sodium salt hydrate) | A racemic mixture of D-threo-isocitric acid and L-threo-isocitric acid; ha… | 1 g | 30378-1 | More Info |
| DL-threo-Isocitric Acid (sodium salt hydrate) | A racemic mixture of D-threo-isocitric acid and L-threo-isocitric acid; ha… | 500 mg | 30378-500 | More Info |
| DL-threo-PDMP (hydrochloride) | An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synth… | 10 mg | 10005276-10 | More Info |
| DL-threo-PDMP (hydrochloride) | An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synth… | 100 mg | 10005276-100 | More Info |
| DL-threo-PDMP (hydrochloride) | An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synth… | 50 mg | 10005276-50 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 100 mg | 17236-100 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 25 mg | 17236-25 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 5 mg | 17236-5 | More Info |
| DL-threo-PPMP (hydrochloride) | An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synth… | 50 mg | 17236-50 | More Info |
| DL-Tryptophan | A racemic mixture of D- and L-tryptophan; serum levels are negatively corr… | 100 g | 31210-100 | More Info |
| DL-Tryptophan | A racemic mixture of D- and L-tryptophan; serum levels are negatively corr… | 25 g | 31210-25 | More Info |
| DL-Tryptophan | A racemic mixture of D- and L-tryptophan; serum levels are negatively corr… | 50 g | 31210-50 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 100 g | 36460-100 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 25 g | 36460-25 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 250 g | 36460-250 | More Info |
| DL-Tyrosine | A racemic mixture of D- and L-tyrosine | 50 g | 36460-50 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 10 mg | 25836-10 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 100 mg | 25836-100 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 250 mg | 25836-250 | More Info |
| D-Luciferin | A chemiluminescent substrate of firefly luciferase which produces light up… | 50 mg | 25836-50 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 1 g | 14681-1 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 100 mg | 14681-100 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 50 mg | 14681-50 | More Info |
| D-Luciferin (potassium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 500 mg | 14681-500 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 1 g | 14682-1 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 100 mg | 14682-100 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 50 mg | 14682-50 | More Info |
| D-Luciferin (sodium salt) | A chemiluminescent substrate of firefly luciferase which produces light up… | 500 mg | 14682-500 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 10 mg | 36862-10 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 25 mg | 36862-25 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 5 mg | 36862-5 | More Info |
| [D-Lys3]-GHRP-6 (trifluoroacetate salt) | An antagonist of GHS-R1a (Ki = 4.25 nM); inhibits ghrelin-induced cAMP acc… | 50 mg | 36862-50 | More Info |
| D-Lysine lactam | A chiral building block; has been used in the synthesis of a chiral synthe… | 100 mg | 31684-100 | More Info |
| D-Lysine lactam | A chiral building block; has been used in the synthesis of a chiral synthe… | 250 mg | 31684-250 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile